New 10-year data from the DANAMI-3-PRIMULTI trial show long-term benefits of complete revascularization for patients with STEMI and multivessel disease compared with treatment of the infarct-related ...

A report on the rising incidence of sudden cardiac deaths among the youth will be submitted by a 12-member technical ...

II, is intended to prospectively validate the diagnostic accuracy of the proprietary CorFlow CoFl system in determining the presence or absence of microvsacular obstruction (MVO) during a primary PCI ...

Health Minister says all corporate and private companies will be directed to mandatorily provide annual health screening for ...

A new study published in the Journal of American Medical Association showed no advantage to immediate coronary angiography ...

The Scott Lynn Kilburg cause of death has suddenly become one of the most searched and talked about topics online, and ...

Researchers have identified that automated scoring of coronary artery calcium (CAC) with standard chest CT scans can predict ...

CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food Drug Administration (FDA) has approved the comp ...

Just a dozen patients have undergone the new treatment that uses electrical pulses to target problem areas inside the heart.

Surviving a cardiac arrest can save your life—but it can also drain your finances. From ICU stays to costly procedures like ...

In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and ...

The history, ECG, age, risk factors, and troponin (HEART) score was developed as a rapid risk stratification tool. It has ...